Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience. - Rossi, B.; Blanche, P.; Roussel‐Robert, V.; Berezné, A.; Combe, S.; Coppo, P.; Guillevin, L.; Le Jeunne, C.; Mouthon, L.; Ounnoughene, N.; Stieltjes, N.; Groh, M. (Haemophilia, 2016)